Circulation Research, Vol 70, 688-696, Copyright © 1992 by American Heart Association

ARTICLES

Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure

T Eschenhagen, U Mende, M Nose, W Schmitz, H Scholz, A Haverich, S Hirt, V Doring, P Kalmar and W Hoppner
Abteilung Allgemeine Pharmakologie, Universitats-Krankenhaus Eppendorf, Universitat Hamburg, FRG.

In human heart failure the positive inotropic and cAMP-elevating effects of both beta-adrenoceptor agonists and phosphodiesterase inhibitors are diminished. This has been explained at least in part by an increase in the inhibitory signal-transducing G protein (Gi) and unchanged stimulatory G protein (Gs). In the present study we determined the mRNA expression pattern of the alpha subunits of Gi-1, Gi-2, Gi-3, and Gs in myocardial tissue samples of patients undergoing heart transplantation. Northern blot analysis of total RNA extracted from left ventricles with 32P-labeled cDNAs demonstrated expression of Gi alpha-2, Gi alpha-3, and Gs alpha mRNA. In contrast, Gi alpha-1 mRNA was not detectable. To investigate whether the increased ratio of Gi/Gs might be due to altered gene expression, we compared mRNA levels of Gi alpha-2, Gi alpha-3, and Gs alpha in left ventricular myocardium from failing hearts with idiopathic dilated cardiomyopathy (n = 8) and ischemic cardiomyopathy (n = 6) and from nonfailing hearts from transplant donors (n = 8). Compared with nonfailing control hearts, the Gi alpha-2 mRNA was increased by 75 +/- 26% (p less than 0.05) in idiopathic dilated cardiomyopathy hearts and 90 +/- 26% (p less than 0.05) in ischemic cardiomyopathy hearts. Gi alpha-3 and Gs alpha mRNA levels were similar in the three groups. The results suggest that as in other mammalian species, Gi alpha-2 and Gi alpha-3 mRNA are the predominant Gi alpha mRNA subtypes in human ventricular myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				N. Hamdani, W. J. Paulus, L. van Heerebeek, A. Borbely, N. M. Boontje, M. J. Zuidwijk, J. G.F. Bronzwaer, W. S. Simonides, H. W. M. Niessen, G. J. M. Stienen, et al. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction Eur. Heart J., August 1, 2009; 30(15): 1863 - 1872. [Abstract] [Full Text] [PDF]

				M. Kobayashi, H. Izawa, X. W. Cheng, H. Asano, A. Hirashiki, K. Unno, S. Ohshima, T. Yamada, Y. Murase, T. S. Kato, et al. Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. Img., November 1, 2008; 1(6): 718 - 726. [Abstract] [Full Text] [PDF]

				W. Zhu, X. Zeng, M. Zheng, and R.-P. Xiao The Enigma of {beta}2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly Circ. Res., September 16, 2005; 97(6): 507 - 509. [Full Text] [PDF]

				S. Bibevski and M. E. Dunlap Prevention of diminished parasympathetic control of the heart in experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785. [Abstract] [Full Text] [PDF]

				G. Selvetella, E. Hirsch, A. Notte, G. Tarone, and G. Lembo Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence Cardiovasc Res, August 15, 2004; 63(3): 373 - 380. [Abstract] [Full Text] [PDF]

				S. Pepe, O. W.V van den Brink, E. G Lakatta, and R.-P. Xiao Cross-talk of opioid peptide receptor and {beta}-adrenergic receptor signalling in the heart Cardiovasc Res, August 15, 2004; 63(3): 414 - 422. [Abstract] [Full Text] [PDF]

				M. A Movsesian Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy Cardiovasc Res, June 1, 2004; 62(3): 450 - 459. [Abstract] [Full Text] [PDF]

				A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res, December 1, 2003; 60(3): 478 - 487. [Abstract] [Full Text] [PDF]

				M. E. Dunlap, S. Bibevski, T. L. Rosenberry, and P. Ernsberger Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1632 - H1640. [Abstract] [Full Text] [PDF]

				R.-P. Xiao, S.-J. Zhang, K. Chakir, P. Avdonin, W. Zhu, R. A. Bond, C. W. Balke, E. G. Lakatta, and H. Cheng Enhanced Gi Signaling Selectively Negates {beta}2-Adrenergic Receptor (AR)- but Not {beta}1-AR-Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts Circulation, September 30, 2003; 108(13): 1633 - 1639. [Abstract] [Full Text] [PDF]

				T. Makino, Y. Hattori, N. Matsuda, H. Onozuka, I. Sakuma, and A. Kitabatake Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade on beta -Adrenoceptor Signaling in Heart Failure Produced by Myocardial Infarction in Rabbits: Reversal of Altered Expression of beta -Adrenoceptor Kinase and Gialpha J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 370 - 379. [Abstract] [Full Text] [PDF]

				C. Mittmann, C. H. Chung, G. Hoppner, C. Michalek, M. Nose, C. Schuler, A. Schuh, T. Eschenhagen, J. Weil, B. Pieske, et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure Cardiovasc Res, September 1, 2002; 55(4): 778 - 786. [Abstract] [Full Text] [PDF]

				P. M.L Janssen, W. Schillinger, J.K. Donahue, O. Zeitz, S. Emami, S. E Lehnart, J. Weil, T. Eschenhagen, G. Hasenfuss, and J. Prestle Intracellular {beta}-blockade: overexpression of G{alpha}i2 depresses the {beta}-adrenergic response in intact myocardium Cardiovasc Res, August 1, 2002; 55(2): 300 - 308. [Abstract] [Full Text] [PDF]

				S.-H. Jo, V. Leblais, P. H. Wang, M. T. Crow, and R.-P. Xiao Phosphatidylinositol 3-Kinase Functionally Compartmentalizes the Concurrent Gs Signaling During {beta}2-Adrenergic Stimulation Circ. Res., July 12, 2002; 91(1): 46 - 53. [Abstract] [Full Text] [PDF]

				B Swynghedauw and D Charlemagne What is wrong with positive inotropic drugs? Lessons from basic science and clinical trials Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D43 - D49. [Abstract] [PDF]

				R.-P. Xiao {beta}-Adrenergic Signaling in the Heart: Dual Coupling of the {beta}2-Adrenergic Receptor to Gs and Gi Proteins Sci. Signal., October 16, 2001; 2001(104): re15 - re15. [Abstract] [Full Text] [PDF]

				V.J Owen, P.B.J Burton, A.J Mullen, E.J Birks, P Barton, and M.H Yacoub Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure Eur. Heart J., June 2, 2001; 22(12): 1015 - 1020. [Abstract] [PDF]

				H. Yoshida, K. Tanonaka, Y. Miyamoto, T. Abe, M. Takahashi, M. B Anand-Srivastava, and S. Takeo Characterization of cardiac myocyte and tissue {beta}-adrenergic signal transduction in rats with heart failure Cardiovasc Res, April 1, 2001; 50(1): 34 - 45. [Abstract] [Full Text] [PDF]

				S. Moniotte, L. Kobzik, O. Feron, J.-N. Trochu, C. Gauthier, and J.-L. Balligand Upregulation of {beta}3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium Circulation, March 27, 2001; 103(12): 1649 - 1655. [Abstract] [Full Text] [PDF]

				R.-P. Xiao Cell Logic for Dual Coupling of a Single Class of Receptors to Gs and Gi Proteins Circ. Res., October 13, 2000; 87(8): 635 - 637. [Full Text] [PDF]

				P. Molenaar, S. Bartel, A. Cochrane, D. Vetter, H. Jalali, P. Pohlner, K. Burrell, P. Karczewski, E.-G. Krause, and A. Kaumann Both {beta}2- and {beta}1-Adrenergic Receptors Mediate Hastened Relaxation and Phosphorylation of Phospholamban and Troponin I in Ventricular Myocardium of Fallot Infants, Consistent With Selective Coupling of {beta}2-Adrenergic Receptors to Gs-Protein Circulation, October 10, 2000; 102(15): 1814 - 1821. [Abstract] [Full Text] [PDF]

				S. Barrere-Lemaire, C. Piot, F. Leclercq, J. Nargeot, and S. Richard Facilitation of L-type calcium currents by diastolic depolarization in cardiac cells: impairment in heart failure Cardiovasc Res, August 1, 2000; 47(2): 336 - 349. [Abstract] [Full Text] [PDF]

				C. A. Walker, F. A. Crawford Jr, and F. G. Spinale MYOCYTE CONTRACTILE DYSFUNCTION WITH HYPERTROPHY AND FAILURE: RELEVANCE TO CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 388 - 400. [Full Text] [PDF]

				G. W. Dorn II, N. M. Tepe, G. Wu, A. Yatani, and S. B. Liggett Mechanisms of Impaired beta -Adrenergic Receptor Signaling in Galpha q-Mediated Cardiac Hypertrophy and Ventricular Dysfunction Mol. Pharmacol., February 1, 2000; 57(2): 278 - 287. [Abstract] [Full Text]

				R.-P. Xiao, H. Cheng, Y.-Y. Zhou, M. Kuschel, and E. G. Lakatta Recent Advances in Cardiac {beta}2-Adrenergic Signal Transduction Circ. Res., November 26, 1999; 85(11): 1092 - 1100. [Abstract] [Full Text] [PDF]

				M. M Borst, P. Szalai, N. Herzog, W. Kubler, and R. H Strasser Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes Cardiovasc Res, October 1, 1999; 44(1): 113 - 120. [Abstract] [Full Text] [PDF]

				M. M. Borst, W. Beuthien, C. Schwencke, P. LaRosee, R. Marquetant, M. Haass, W. Kubler, and R. H. Strasser Desensitization of the pulmonary adenylyl cyclase system: A cause of airway hyperresponsiveness in congestive heart failure? J. Am. Coll. Cardiol., September 1, 1999; 34(3): 848 - 856. [Abstract] [Full Text] [PDF]

				N. Dzimiri Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502. [Abstract] [Full Text] [PDF]

				S. Bibevski and M. E. Dunlap Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure Circulation, June 8, 1999; 99(22): 2958 - 2963. [Abstract] [Full Text] [PDF]

				I. Espinasse, V. Iourgenko, C. Richer, M. Heimburger, N. Defer, M.-C. Bourin, F. Samson, E. Pussard, J.-F. Giudicelli, J.-B. Michel, et al. Decreased type VI adenylyl cyclase mRNA concentration and Mg2+-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn2+-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure Cardiovasc Res, April 1, 1999; 42(1): 87 - 98. [Abstract] [Full Text] [PDF]

				D. J. Peterson, H. Ju, J. Hao, M. Panagia, D. C. Chapman, and I. M.C. Dixon Expression of Gi-2{alpha} and Gs{alpha} in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction Cardiovasc Res, March 1, 1999; 41(3): 575 - 585. [Abstract] [Full Text] [PDF]

				R.-P. Xiao, P. Avdonin, Y.-Y. Zhou, H. Cheng, S. A. Akhter, T. Eschenhagen, R. J. Lefkowitz, W. J. Koch, and E. G. Lakatta Coupling of ß2-Adrenoceptor to Gi Proteins and Its Physiological Relevance in Murine Cardiac Myocytes Circ. Res., January 22, 1999; 84(1): 43 - 52. [Abstract] [Full Text] [PDF]

				A. Kaumann, S. Bartel, P. Molenaar, L. Sanders, K. Burrell, D. Vetter, P. Hempel, P. Karczewski, and E.-G. Krause Activation of ß2-Adrenergic Receptors Hastens Relaxation and Mediates Phosphorylation of Phospholamban, Troponin I, and C-Protein in Ventricular Myocardium From Patients With Terminal Heart Failure Circulation, January 12, 1999; 99(1): 65 - 72. [Abstract] [Full Text] [PDF]

				B. Stein, T. Eschenhagen, J. Rudiger, H. Scholz, U. Forstermann, and I. Gath Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1179 - 1186. [Abstract] [Full Text] [PDF]

				C Mittmann, T Eschenhagen, and H Scholz Cellular and molecular aspects of contractile dysfunction in heart failure Cardiovasc Res, August 1, 1998; 39(2): 267 - 275. [Full Text] [PDF]

				J. Weil, T. Eschenhagen, S. Hirt, O. Magnussen, C. Mittmann, U. Remmers, and H. Scholz Preserved Frank-Starling mechanism in human end stage heart failure Cardiovasc Res, February 1, 1998; 37(2): 541 - 548. [Abstract] [Full Text] [PDF]

				F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, M. L. Webb, R. B. Hird, M. J. Cavallo, J. R. Powell, and W. H. Koster Angiotensin-Converting Enzyme Inhibition and Angiotensin II Subtype-1 Receptor Blockade during the Progression of Left Ventricular Dysfunction: Differential Effects on Myocyte Contractile Processes J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1082 - 1094. [Abstract] [Full Text]

				D. E. Vatner, N. Sato, J. B. Galper, and S. F. Vatner Physiological and Biochemical Evidence for Coordinate Increases in Muscarinic Receptors and Gi During Pacing-Induced Heart Failure Circulation, July 1, 1996; 94(1): 102 - 107. [Abstract] [Full Text]

				R. B. Hird, T. W. Wakefield, R. Mukherjee, B. U. Jones, F. A. Crawford, P. C. Andrews, J. C. Stanley, and F. G. Spinale Direct Effects of Protamine Sulfate on Myocyte Contractile Processes : Cellular and Molecular Mechanisms Circulation, November 1, 1995; 92(9): 433 - 446. [Abstract] [Full Text]

				A. Sanbe and S. Takeo Long-term Treatment With Angiotensin I–Converting Enzyme Inhibitors Attenuates the Loss of Cardiac ß-Adrenoceptor Responses in Rats With Chronic Heart Failure Circulation, November 1, 1995; 92(9): 2666 - 2675. [Abstract] [Full Text]

				F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, R. B. Hird, J. D. Walker, A. Arnim-Barker, J. R. Powell, and W. H. Koster Angiotensin-Converting Enzyme Inhibition and the Progression of Congestive Cardiomyopathy : Effects on Left Ventricular and Myocyte Structure and Function Circulation, August 1, 1995; 92(3): 562 - 578. [Abstract] [Full Text]

				M. Bohm, C. Grabel, M. Flesch, A. Knorr, and E. Erdmann Treatment in Hypertensive Cardiac Hypertrophy, II : Postreceptor Events Hypertension, May 1, 1995; 25(5): 962 - 970. [Abstract] [Full Text]

				C. Boixel, W. Gonzalez, L. Louedec, and S. N. Hatem Mechanisms of L-Type Ca2+ Current Downregulation in Rat Atrial Myocytes During Heart Failure Circ. Res., September 28, 2001; 89(7): 607 - 613. [Abstract] [Full Text] [PDF]